Bulletin Health Systems and Services - PAHO - February 2022
2 March, 2022
PAHO launches 120th Anniversary campaign
The Pan American Health Organization (PAHO) kicks off its anniversary campaign to celebrate 120 years of active work promoting health and wellbeing throughout the Americas. The 120th Anniversary campaign aims to spur efforts to champion pro-equity strategies for universal access to health and universal health coverage, and to promote the urgent need for robust health systems that are sufficiently ready and resourced to meet current and future health challenges.
Despite overall drop in new infections, pandemic continues to challenge health care workers in the Americas
PAHO warns that recent surge in COVID-19 cases has overburdened struggling systems. Countries must urgently increase staff and training and prioritize health care workers for vaccination. [...] A PAHO study shows that over the course of the pandemic, doctors, nurses, and other frontline health workers saw more patients, worked longer hours, and suffered higher rates of COVID-19 infection.
PAHO and Evidence Aid preset a collection of systematic reviews on resilient health systems in the context of disasters and other health emergencies
To contribute to decision-making supported by reliable research evidence, PAHO and Evidence Aid presented in a webinar the initial collection of 124 summaries of systematic reviews analyzed with Evidence Aid's methodology on topics that PAHO identified as relevant to health systems in the region. [Available in Spanish]
55% of children and adolescents with cancer recover in Latin America and the Caribbean
To mark the International Day against Childhood Cancer, the Pan American Health Organization calls for improvements in survival rates of children and adolescents with cancer, currently at 55% in Latin America and the Caribbean. [...] Through its Strategic Fund, PAHO is also participating in a recent global project led by WHO and St. Jude Children's Research Hospital in the United States to expand access to life-saving drugs to treat childhood cancer in middle- and low-income countries.